Cohance Lifesciences Limited
COHANCE
Clasificación en acciones
#6340
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Precio por acción
$5.11
Capitalización bursátil
$1.95B
Cambio (1 día)
1.14%
Cambio (1 año)
-56.89%
País
IN
Comercio Cohance Lifesciences Limited (COHANCE)
Categoría
Healthcare
Ganancias de Cohance Lifesciences Limited (COHANCE)
Ganancias en Jun 2025 TTM: $37.76M
Secondo gli ultimi rapporti finanziari di Cohance Lifesciences Limited, gli utili attuali della società sono $37.76M. Nel 2024, la società ha registrato un utile di $48.65M, una disminución en comparación con agli utili del 2023, che erano di $68.11M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Cohance Lifesciences Limited desde 2019 hasta 2026
Ganancias al final de cada año
| Año | Ganancias | Cambiar |
|---|---|---|
| 2026 (TTM) | $37.76M | -6.11% |
| 2025 | $40.21M | -17.35% |
| 2024 | $48.65M | -28.57% |
| 2023 | $68.11M | -22.55% |
| 2022 | $87.95M | 37.66% |
| 2021 | $63.89M | 18.98% |
| 2020 | $53.70M | 136.19% |
| 2019 | $22.73M | 0.00% |
Ganancias de empresas similares o competidoras
| Empresa | Ganancias | Diferencia de ganancias | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 4,573.48% |
IN
|
